<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>938</number>
    <updateDate>2022-11-01T15:17:46Z</updateDate>
    <updateDateIncludingText>2022-11-01T15:17:46Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <type>HR</type>
    <introducedDate>2019-01-31</introducedDate>
    <congress>116</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 165, Number 20 (Thursday, January 31, 2019)][House]From the Congressional Record Online through the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]By Mr. SCHRADER:H.R. 938.Congress has the power to enact this legislation pursuantto the following:This bill is enacted pursuant to the power granted toCongress under Article I, Section 8, Clause 3 of the UnitedStates Constitution.[Page H1342]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Reported by</name>
                <date>2019-03-27T16:24:10Z</date>
              </item>
              <item>
                <name>Markup by</name>
                <date>2019-03-27T16:24:03Z</date>
              </item>
              <item>
                <name>Referred to</name>
                <date>2019-02-02T17:14:51Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2019-05-02T18:02:35Z</date>
          </item>
          <item>
            <name>Markup by</name>
            <date>2019-04-03T19:59:49Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2019-01-31T17:01:10Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 116-46</citation>
      </committeeReport>
    </committeeReports>
    <relatedBills>
      <item>
        <title>Lower Costs, More Cures Act of 2019</title>
        <congress>116</congress>
        <number>19</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-12-19</actionDate>
          <text>Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Strengthening Health Care and Lowering Prescription Drug Costs Act</title>
        <congress>116</congress>
        <number>987</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-05-20</actionDate>
          <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act</title>
        <congress>116</congress>
        <number>2700</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-06-26</actionDate>
          <text>Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2019-05-02</actionDate>
        <text>Placed on the Union Calendar, Calendar No. 24.</text>
        <type>Calendars</type>
        <actionCode>H12410</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <calendarNumber>
          <calendar>U00024</calendar>
        </calendarNumber>
      </item>
      <item>
        <actionDate>2019-05-02</actionDate>
        <text>Reported by the Committee on Energy and Commerce. H. Rept. 116-46.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2019-05-02</actionDate>
        <text>Reported by the Committee on Energy and Commerce. H. Rept. 116-46.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2019-04-03</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported by Voice Vote.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-04-03</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-03-27</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Forwarded by Subcommittee to Full Committee by Voice Vote .</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-03-27</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Subcommittee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-02-02</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-01-31</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2019-01-31</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2019-01-31</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>S001180</bioguideId>
        <fullName>Rep. Schrader, Kurt [D-OR-5]</fullName>
        <firstName>Kurt</firstName>
        <lastName>Schrader</lastName>
        <party>D</party>
        <state>OR</state>
        <district>5</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>C001103</bioguideId>
        <fullName>Rep. Carter, Earl L. "Buddy" [R-GA-1]</fullName>
        <firstName>Earl</firstName>
        <lastName>Carter</lastName>
        <party>R</party>
        <state>GA</state>
        <middleName>L. "Buddy"</middleName>
        <district>1</district>
        <sponsorshipDate>2019-01-31</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001119</bioguideId>
        <fullName>Rep. Craig, Angie [D-MN-2]</fullName>
        <firstName>Angie</firstName>
        <lastName>Craig</lastName>
        <party>D</party>
        <state>MN</state>
        <district>2</district>
        <sponsorshipDate>2019-03-25</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000624</bioguideId>
        <fullName>Rep. Dingell, Debbie [D-MI-12]</fullName>
        <firstName>Debbie</firstName>
        <lastName>Dingell</lastName>
        <party>D</party>
        <state>MI</state>
        <district>12</district>
        <sponsorshipDate>2019-03-26</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>R000599</bioguideId>
        <fullName>Rep. Ruiz, Raul [D-CA-36]</fullName>
        <firstName>Raul</firstName>
        <lastName>Ruiz</lastName>
        <party>D</party>
        <state>CA</state>
        <district>36</district>
        <sponsorshipDate>2019-03-26</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>P000034</bioguideId>
        <fullName>Rep. Pallone, Frank, Jr. [D-NJ-6]</fullName>
        <firstName>FRANK</firstName>
        <lastName>PALLONE</lastName>
        <party>D</party>
        <state>NJ</state>
        <district>6</district>
        <sponsorshipDate>2019-03-26</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>E000215</bioguideId>
        <fullName>Rep. Eshoo, Anna G. [D-CA-18]</fullName>
        <firstName>ANNA</firstName>
        <lastName>ESHOO</lastName>
        <party>D</party>
        <state>CA</state>
        <middleName>G.</middleName>
        <district>18</district>
        <sponsorshipDate>2019-03-26</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>K000379</bioguideId>
        <fullName>Rep. Kennedy, Joseph P., III [D-MA-4]</fullName>
        <firstName>Joseph</firstName>
        <lastName>Kennedy</lastName>
        <party>D</party>
        <state>MA</state>
        <middleName>P.</middleName>
        <district>4</district>
        <sponsorshipDate>2019-03-27</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001163</bioguideId>
        <fullName>Rep. Matsui, Doris O. [D-CA-6]</fullName>
        <firstName>Doris</firstName>
        <lastName>Matsui</lastName>
        <party>D</party>
        <state>CA</state>
        <middleName>O.</middleName>
        <district>6</district>
        <sponsorshipDate>2019-03-27</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>R000515</bioguideId>
        <fullName>Rep. Rush, Bobby L. [D-IL-1]</fullName>
        <firstName>BOBBY</firstName>
        <lastName>RUSH</lastName>
        <party>D</party>
        <state>IL</state>
        <middleName>L.</middleName>
        <district>1</district>
        <sponsorshipDate>2019-03-27</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>V000133</bioguideId>
        <fullName>Rep. Van Drew, Jefferson [D-NJ-2]</fullName>
        <firstName>Jefferson</firstName>
        <lastName>Van Drew</lastName>
        <party>D</party>
        <state>NJ</state>
        <district>2</district>
        <sponsorshipDate>2019-03-29</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001067</bioguideId>
        <fullName>Rep. Clarke, Yvette D. [D-NY-9]</fullName>
        <firstName>Yvette</firstName>
        <lastName>Clarke</lastName>
        <party>D</party>
        <state>NY</state>
        <middleName>D.</middleName>
        <district>9</district>
        <sponsorshipDate>2019-04-02</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>W000791</bioguideId>
        <fullName>Rep. Walden, Greg [R-OR-2]</fullName>
        <firstName>GREG</firstName>
        <lastName>WALDEN</lastName>
        <party>R</party>
        <state>OR</state>
        <district>2</district>
        <sponsorshipDate>2019-04-08</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S001145</bioguideId>
        <fullName>Rep. Schakowsky, Janice D. [D-IL-9]</fullName>
        <firstName>JANICE</firstName>
        <lastName>SCHAKOWSKY</lastName>
        <party>D</party>
        <state>IL</state>
        <middleName>D.</middleName>
        <district>9</district>
        <sponsorshipDate>2019-04-08</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001209</bioguideId>
        <fullName>Rep. McAdams, Ben [D-UT-4]</fullName>
        <firstName>Ben</firstName>
        <lastName>McAdams</lastName>
        <party>D</party>
        <state>UT</state>
        <district>4</district>
        <sponsorshipDate>2019-04-10</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001207</bioguideId>
        <fullName>Rep. Mucarsel-Powell, Debbie [D-FL-26]</fullName>
        <firstName>Debbie</firstName>
        <lastName>Mucarsel-Powell</lastName>
        <party>D</party>
        <state>FL</state>
        <district>26</district>
        <sponsorshipDate>2019-04-29</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001187</bioguideId>
        <fullName>Rep. Meadows, Mark [R-NC-11]</fullName>
        <firstName>Mark</firstName>
        <lastName>Meadows</lastName>
        <party>R</party>
        <state>NC</state>
        <district>11</district>
        <sponsorshipDate>2019-05-01</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2019-04-30T21:25:00Z</pubDate>
        <title>H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019</title>
        <url>https://www.cbo.gov/publication/55187</url>
        <description>As ordered reported by the House Committee on Energy and Commerce on April 3, 2019</description>
      </item>
    </cboCostEstimates>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Competition and antitrust</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Health care costs and insurance</name>
        </item>
        <item>
          <name>Health care coverage and access</name>
        </item>
        <item>
          <name>Licensing and registrations</name>
        </item>
        <item>
          <name>Marketing and advertising</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2019-01-31</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2021-09-01T17:30:25Z</updateDate>
        <text><![CDATA[ <p><b>Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the</b> <b>BLOCKING Act of 2019 </b></p> <p>This bill modifies provisions related to market exclusivity for a generic drug.</p> <p>Currently, the Food and Drug Administration (FDA) awards 180 days of exclusivity on the market to a first applicant to file a qualifying application for market approval of a generic drug. Generally, this exclusivity period begins upon a first applicant's commercial marketing of the drug.</p> <p>The bill authorizes the FDA to approve a subsequent generic drug application prior to a first applicant's first date of commercial marketing if (1) the subsequent application is ready for full approval, (2) a first applicant's application has been pending for at least 30 months, and (3) the approval of a first applicant's application is not precluded by patent infringement claims asserted against that first applicant.</p>]]></text>
      </summary>
      <summary>
        <versionCode>07</versionCode>
        <actionDate>2019-05-02</actionDate>
        <actionDesc>Reported to House</actionDesc>
        <updateDate>2021-09-10T15:23:29Z</updateDate>
        <text><![CDATA[ <p><b>Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the</b> <b>BLOCKING Act of 2019 </b></p> <p>This bill modifies provisions related to market exclusivity for a generic drug.</p> <p>Currently, the Food and Drug Administration (FDA) awards 180 days of exclusivity on the market to a first applicant to file a qualifying application for market approval of a generic drug. Generally, this exclusivity period begins upon a first applicant's commercial marketing of the drug.</p> <p>The bill authorizes the FDA to approve a subsequent generic drug application prior to a first applicant's first date of commercial marketing if (1) the subsequent application is ready for full approval, (2) a first applicant's application has been pending for at least 30 months, and (3) the approval of a first applicant's application is not precluded by patent infringement claims asserted against that first applicant.</p>]]></text>
      </summary>
    </summaries>
    <title>BLOCKING Act of 2019</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>BLOCKING Act of 2019</title>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>BLOCKING Act of 2019</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to House</titleType>
        <title>BLOCKING Act of 2019</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to House</titleType>
        <title>Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act, with respect to eligibility for approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval, and for other purposes.</title>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Reported in House</type>
        <date>2019-05-02T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr938rh/xml/BILLS-116hr938rh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2019-01-31T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr938ih/xml/BILLS-116hr938ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2019-05-02</actionDate>
      <text>Placed on the Union Calendar, Calendar No. 24.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
